Akebia Therapeutics, Inc.
AKBA
$1.45
$0.031.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.05% | 21.22% | 21.11% | 118.57% | 52.47% |
| Total Receivables | -28.98% | -9.05% | 18.32% | 79.06% | 6.83% |
| Inventory | -16.27% | 11.58% | -15.33% | 21.48% | -20.74% |
| Prepaid Expenses | -- | -- | -- | -69.69% | -44.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -22.15% | -10.29% | -1.07% | 8.14% | 17.87% |
| Total Current Assets | -2.08% | 10.09% | 15.15% | 79.02% | 13.69% |
|
|
|||||
| Total Current Assets | -2.08% | 10.09% | 15.15% | 79.02% | 13.69% |
| Net Property, Plant & Equipment | -22.58% | -18.06% | -14.60% | -13.44% | -11.96% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 47.50% | -8.44% | 15.26% | 2.58% | 37.75% |
| Total Assets | 3.41% | 5.37% | 11.42% | 40.57% | 6.53% |
|
|
|||||
| Total Accounts Payable | 110.02% | -12.70% | -8.72% | -16.61% | 12.49% |
| Total Accrued Expenses | 20.92% | 28.81% | 48.68% | 19.57% | 18.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.44% | 12.78% | 31.31% | 39.53% | 29.09% |
| Total Finance Division Other Current Liabilities | 0.09% | -10.54% | 19.76% | 10.92% | 37.72% |
| Total Other Current Liabilities | 0.09% | -10.54% | 19.76% | 10.92% | 37.72% |
| Total Current Liabilities | 22.16% | 12.35% | 30.13% | 12.75% | 23.14% |
|
|
|||||
| Total Current Liabilities | 22.16% | 12.35% | 30.13% | 12.75% | 23.14% |
| Long-Term Debt | -1.52% | 0.85% | -1.38% | 2.54% | 93.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -68.39% | -40.15% | -28.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -53.11% | -47.61% | 58.54% | 24.27% | -89.68% |
| Total Liabilities | 6.63% | 1.96% | 10.77% | 5.84% | 4.78% |
|
|
|||||
| Common Stock & APIC | 0.19% | 0.70% | 0.26% | 4.15% | 1.50% |
| Retained Earnings | -0.73% | 0.03% | 0.01% | 0.36% | -1.38% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -21.60% | 42.32% | 18.89% | 149.98% | 2.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.60% | 42.32% | 18.89% | 149.98% | 2.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.60% | 42.32% | 18.89% | 149.98% | 2.41% |
|
|
|||||